Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Alexopoulos
Anastasios Delopoulos

Showing results (401-410 of 429) with videos related to

Pageof 43
Sort By:
Angiology|March 3, 2020
Antithrombotic Therapy in Patients With Prior Stroke/Transient Ischemic Attack and Acute Coronary SyndromesDongfeng Zhang, Xiantao Song, Yalei Chen, et al.
Thrombosis Research|June 2, 2018
Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registryCarme Guerrero, Alberto Garay, Albert Ariza-Solé, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 31, 2016
BleeMACS: rationale and design of the studyFabrizio D'Ascenzo, Emad Abu-Assi, Sergio Raposeiras-Roubín, et al.
International Journal of Cardiology|December 2, 2019
Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelorMatteo Bianco, Fabrizio D'ascenzo, Sergio Raposeiras Roubin, et al.
International Journal of Cardiology|July 13, 2016
Impact of blood transfusion on in-hospital myocardial infarctions according to patterns of acute coronary syndrome: Insights from the BleeMACS registrySebastiano Gili, Fabrizio D'Ascenzo, Marco Francesco Lococo, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 15, 2016
Optimal Medical Therapy in Patients with Malignancy Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome: a BleeMACS Sub-StudyMario Iannaccone, Fabrizio D Ascenzo, Ovidio De Filippo, et al.
International Journal of Cardiology|July 9, 2016
Safety and effectiveness of the new P2Y12r inhibitor agents vs clopidogrel in ACS patients according to the geographic area: East Asia vs EuropeFrancesca Giordana, Antonio Montefusco, Fabrizio D'Ascenzo, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 26, 2018
Association of Beta-Blockers with Survival on Patients Presenting with ACS Treated with PCI: A Propensity Score Analysis from the BleeMACS RegistryFabrizio D'Ascenzo, Dario Celentani, Alessandro Brustio, et al.
JAMA Network Open|June 25, 2020
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical TrialSpyridon G Deftereos, Georgios Giannopoulos, Dimitrios A Vrachatis, et al.
Revista Espanola De Cardiologia (English Ed.)|May 21, 2019
Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fractionSergio Raposeiras-Roubín, Emad Abu-Assi, María Cespón-Fernández, et al.
Pageof 43

Showing results (401-410 of 429) with videos related to

Sort By:
Pageof 43
Angiology|March 3, 2020
Antithrombotic Therapy in Patients With Prior Stroke/Transient Ischemic Attack and Acute Coronary SyndromesDongfeng Zhang, Xiantao Song, Yalei Chen, et al.
Thrombosis Research|June 2, 2018
Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registryCarme Guerrero, Alberto Garay, Albert Ariza-Solé, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 31, 2016
BleeMACS: rationale and design of the studyFabrizio D'Ascenzo, Emad Abu-Assi, Sergio Raposeiras-Roubín, et al.
International Journal of Cardiology|December 2, 2019
Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelorMatteo Bianco, Fabrizio D'ascenzo, Sergio Raposeiras Roubin, et al.
International Journal of Cardiology|July 13, 2016
Impact of blood transfusion on in-hospital myocardial infarctions according to patterns of acute coronary syndrome: Insights from the BleeMACS registrySebastiano Gili, Fabrizio D'Ascenzo, Marco Francesco Lococo, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 15, 2016
Optimal Medical Therapy in Patients with Malignancy Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome: a BleeMACS Sub-StudyMario Iannaccone, Fabrizio D Ascenzo, Ovidio De Filippo, et al.
International Journal of Cardiology|July 9, 2016
Safety and effectiveness of the new P2Y12r inhibitor agents vs clopidogrel in ACS patients according to the geographic area: East Asia vs EuropeFrancesca Giordana, Antonio Montefusco, Fabrizio D'Ascenzo, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 26, 2018
Association of Beta-Blockers with Survival on Patients Presenting with ACS Treated with PCI: A Propensity Score Analysis from the BleeMACS RegistryFabrizio D'Ascenzo, Dario Celentani, Alessandro Brustio, et al.
JAMA Network Open|June 25, 2020
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical TrialSpyridon G Deftereos, Georgios Giannopoulos, Dimitrios A Vrachatis, et al.
Revista Espanola De Cardiologia (English Ed.)|May 21, 2019
Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fractionSergio Raposeiras-Roubín, Emad Abu-Assi, María Cespón-Fernández, et al.
Pageof 43